Related Experiment Video
Updated: Mar 26, 2026
08:01
Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
Published on: March 16, 2016
45.0K
Alzheimer's disease: Targeting the Cholinergic System
Talita H Ferreira-Vieira, Isabella M Guimaraes, Flavia R Silva
1Departamento de Bioquimica e Imunologia, Instituto de Ciencias Biologicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. fmribeiro@icb.ufmg.br.
Current Neuropharmacology
|January 28, 2016
Summary
Alzheimer's disease (AD) involves the loss of acetylcholine-producing neurons, impacting memory and attention. Targeting the cholinergic system offers a promising therapeutic strategy for AD patients.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Acetylcholine (ACh) is a vital neurotransmitter in the central and peripheral nervous systems.
- Dysfunction and loss of cholinergic neurons, particularly in the basal forebrain, are implicated in Alzheimer's disease (AD).
Purpose of the Study:
- To explore the role of the cholinergic system in neurodegenerative diseases like AD.
- To evaluate the potential of targeting the cholinergic system for AD therapeutics.
Main Methods:
- The abstract discusses the synthesis, transport, receptors, and degradation of acetylcholine.
- It highlights the loss of cholinergic neurons in Alzheimer's disease and its correlation with cognitive decline.
Main Results:
- Synaptic loss, rather than amyloid plaques, is the primary correlate of cognitive impairment progression in AD.
- Loss of cholinergic neurons significantly contributes to memory and attention deficits in AD patients.
Conclusions:
- The cholinergic system is critically involved in cognitive functions affected by Alzheimer's disease.
- Pharmacological interventions targeting the cholinergic system present a promising avenue for AD treatment.
More Related Videos
Related Concept Videos
01:22Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
01:26Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
1.8K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.8K
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
2.0K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
2.0K
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
818
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
818
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
2.0K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
2.0K